2019

Cellectar Biosciences Announces Closing of $10.0 Million Financing

ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering

Atreca Announces Pricing of Initial Public Offering

Chiasma Announces Pricing of Underwritten Public Offering of $55.0 Million of Common Stock

BioCardia Announces Closing of $10.0 Million Public Offering

Vaxart Announces Pricing of $8 Million Underwritten Public Offering

Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering

SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants

Aquestive Therapeutics Announces Pricing of Public Offering of Common Stock

Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock